Pharmafile Logo
Pharmafocus logo
Advanced Search

primevigilance

Showing 10 posts of 10 posts found.

PrimeVigilance celebrates its 10th anniversary

April 13, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance

PrimeVigilance will be exhibiting and celebrating its 10th anniversary at #DIAEurope2018, raffling 10 bottles of champagne away! Stop by their …

News
Press release
better_q_image

Intelligent Automation in Pharmacovigilance

November 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, pharmacovigilance, primevigilance

PrimeVigilance is pleased to announce their collaboration with the International Society of Pharmacovigilance (ISoP) on the upcoming seminar, organised by …

News
news

Free Webinar: EudraVigilance changes and the impact on MAHs

October 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance

Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.

News
new_brand_image_sept_2017

PrimeVigilance launches new brand and logo

September 12, 2017
Manufacturing and Production, Sales and Marketing pharmacovigilance, primevigilance

PrimeVigilance has launched its new visual identity together with a new website. Additionally, it has begun harmonising its appearance within …

News

PrimeVigilance is committed to minimising the impact of UK’s Withdrawal from the EU

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, primevigilance

Guildford, UK 14th  June, 2017

News
Press release

Free Pharmacovigilance Webinar: Available to view now!

November 14, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance

Pharmafocus, alongside PrimeVigilance, hosted a webinar on 10 November and is now available to view for free.Throughout the webinar, PrimeVigilance …

News
banner_3

Free Pharmacovigilance Webinar: Just two days left to register!

November 7, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance

There are only two more days to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …

News
stephen_stamp

Ergomed announces board changes

January 19, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ergomed, primevigilance

Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …

Appointment

PrimeVigilance and Sound Opinion join forces

May 26, 2015
acquisition, medical information, primevigilance

Ergomed plc, the parent company of PrimeVigilance, has acquired Sound Opinion, one of the UK’s leading Medical Information (MI) service …

News
Press release
joerg_seebeck

PrimeVigilance appoints chief medical officer

April 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance, seebeck

Pharmacovigilance and medical services firm PrimeVigilance has appointed Dr Joerg Seebeck as its chief medical officer.  Seebeck is to head …

Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026